Jack Nathan Medical Corp (V:JNH) — Stock Price
Jack Nathan Medical Corp (V:JNH) is currently trading at CA$0.01 CAD, up 0.00% today. Over the past 52 weeks, shares have ranged between CA$0.01 and CA$0.01. This page tracks Jack Nathan Medical Corp's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Jack Nathan Medical Corp worth.
Jack Nathan Medical Corp (JNH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Jack Nathan Medical Corp's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Jack Nathan Medical Corp Income Statement — Revenue, Profit & Earnings by Year
Jack Nathan Medical Corp's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2023 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CA$17.42 Million | CA$15.49 Million | CA$9.64 Million | CA$3.85 Million | CA$0.00 |
| Cost of Revenue | CA$4.56 Million | CA$3.67 Million | CA$2.71 Million | CA$74.43K | — |
| Gross Profit | CA$12.86 Million | CA$11.82 Million | CA$6.92 Million | CA$3.78 Million | — |
| Research & Development | CA$149.91K | CA$236.93K | CA$546.06K | CA$102.00K | — |
| SG&A | — | CA$15.82 Million | CA$12.81 Million | CA$4.41 Million | CA$134.62K |
| Total Operating Expenses | CA$21.48 Million | CA$20.79 Million | CA$16.58 Million | CA$4.73 Million | CA$134.62K |
| Operating Income | CA$-4.72 Million | CA$-5.31 Million | CA$-6.94 Million | CA$-876.24K | CA$-134.62K |
| EBITDA | — | CA$-5.51 Million | CA$-7.54 Million | CA$-10.11 Million | — |
| EBIT | — | CA$-5.20 Million | CA$-6.55 Million | CA$-805.41K | CA$-134.62K |
| Interest Expense | — | CA$409.51K | CA$181.85K | CA$36.23K | CA$0.00 |
| Income Before Tax | CA$-6.64 Million | CA$-6.99 Million | CA$-8.23 Million | CA$-10.29 Million | CA$-134.62K |
| Income Tax Expense | — | CA$-85.97K | CA$-217.54K | CA$-380.92K | CA$-23.40K |
| Net Income | — | CA$-7.08 Million | CA$-7.81 Million | CA$-9.91 Million | CA$-134.62K |
Jack Nathan Medical Corp Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Jack Nathan Medical Corp's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Total Assets | CA$6.45 Million | CA$8.14 Million | CA$10.65 Million | CA$406.78K | CA$84.20K |
| Total Current Assets | CA$2.51 Million | CA$2.24 Million | CA$8.15 Million | CA$107.81K | CA$774.24K |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | CA$826.94K | CA$831.91K | CA$156.62K | CA$63.89K | CA$258.89K |
| Inventory | — | — | — | — | — |
| Property, Plant & Equipment | CA$2.56 Million | CA$2.61 Million | CA$1.23 Million | CA$869.79K | CA$351.88K |
| Goodwill | CA$0.00 | CA$1.01 Million | CA$598.61K | CA$0.00 | — |
| Total Liabilities | CA$8.32 Million | CA$4.06 Million | CA$2.13 Million | CA$17.18K | CA$8.00K |
| Total Current Liabilities | CA$5.61 Million | CA$2.70 Million | CA$960.11K | CA$1.90 Million | CA$2.23 Million |
| Long-term Debt | CA$1.67 Million | CA$106.58K | CA$180.10K | — | — |
| Net Debt | CA$2.33 Million | — | — | CA$750.02K | — |
| Total Stockholder Equity | CA$-1.87 Million | CA$4.08 Million | CA$8.53 Million | CA$389.59K | CA$76.20K |
| Retained Earnings | CA$-25.92 Million | CA$-19.02 Million | CA$-10.99 Million | CA$-1.09 Million | CA$264.32K |
Jack Nathan Medical Corp Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Jack Nathan Medical Corp generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-2.00 Million | CA$-4.34 Million | CA$-809.16K | CA$-375.55K | CA$485.65K |
| Capital Expenditures | CA$2.59 Million | CA$950.90K | CA$499.74K | CA$255.49K | CA$274.08K |
| Free Cash Flow | CA$-4.59 Million | CA$-5.29 Million | CA$-1.31 Million | CA$-66.53K | CA$-33.69K |
| Investing Cash Flow | CA$-2.76 Million | CA$-2.14 Million | CA$-252.89K | CA$-255.49K | CA$-274.08K |
| Financing Cash Flow | CA$5.35 Million | CA$-164.43K | CA$8.68 Million | CA$166.66K | CA$12.07K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$1.13 Million | CA$2.50 Million | CA$839.02K | CA$58.90K | — |
| Depreciation | CA$1.07 Million | CA$516.12K | CA$144.84K | CA$110.44K | CA$24.30K |
| Change in Cash | CA$397.65K | CA$-6.62 Million | CA$7.69 Million | CA$-478.58K | CA$206.61K |
Jack Nathan Medical Corp Earnings History — EPS Actual vs. Analyst Estimates
Track Jack Nathan Medical Corp's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Dec 29, 2025 | — | — | — |
| Sep 29, 2025 | — | — | — |
| Jul 14, 2025 | — | — | — |
| Apr 30, 2023 | -0.01 | — | — |
| Jan 31, 2023 | -0.04 | — | — |
| Oct 31, 2022 | -0.01 | — | — |
| Jul 31, 2022 | -0.02 | — | — |
| Apr 30, 2022 | -0.02 | — | — |